Clinical Trials

69 enrolled

Breast Neoplasms

NCT06280781 2026-03-30

IP9-ATLAS

Phase NA Not yet recruiting

1,263 enrolled

Genitourinary

Prostatic Neoplasms

NCT07277738 2026-03-25

PSID

78 enrolled

Breast Neoplasms

NCT04545814 2026-03-24

Analyzing Preoperative Stereotactic Radiosurgery With Gamma Knife Icon for Brain Metastases

Phase NA Completed

11 enrolled 11 charts

Phase NA Not yet recruiting

Brain Neoplasms

NCT07488780 2026-03-23

Language Network Prehab Via fMRI Neurofeedback

4 enrolled

Glioma

NCT05191940 2026-03-20

LAPC

30 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT05595577 2026-03-20

PALS

110 enrolled

BreastLymphoid

Breast Neoplasms, Hodgkin Disease, Lymphoma, Non-Hodgkin

NCT04030507 2026-03-19

Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer

214 enrolled

Breast Neoplasms, Inflammatory Breast Neoplasms, Triple Negative Breast Neoplasms

NCT02553967 2026-03-17

REMASCO

Phase NA Completed

49 enrolled

Phase 3 Not yet recruiting

Breast Neoplasms

NCT03258593 2026-03-17

Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG)

Phase 1 Completed

15 enrolled 21 charts

Genitourinary

Urinary Bladder Neoplasms, Carcinoma in Situ

NCT07472868 2026-03-16

MEND-IT II

394 enrolled

Pathologic Complete Response

NCT02858310 2026-03-09

E7 TCR T Cells for Human Papillomavirus-Associated Cancers

Phase 1/2 Completed

224 enrolled 15 charts

Gynecologic

Carcinoma in Situ, Uterine Cervical Dysplasia, Vulvar Diseases, Vulvar Neoplasms, Papillomavirus Infections

NCT07458906 2026-03-09

DLL3-Targeted PET/CT in Neuroendocrine Carcinoma

60 enrolled

Endocrine

Carcinoma, Neuroendocrine

NCT06819475 2026-03-06

Imaging Skeletal Muscle Mitochondrial OXPHOS Activity In Acute Lymphoblastic Leukemia Survivors

LymphoidOther hematologic neoplasm

60 enrolled

Neoplasms, Muscle Weakness, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04197297 2026-03-05

Brain Imaging Biomarkers in Patients With Brain Metastasis

Phase 2 Recruiting

90 enrolled

Phase NA Enrolling by invitation

Brain Neoplasms

NCT06238661 2026-03-05

ProScreenMRI

4,500 enrolled

Genitourinary

Prostatic Neoplasms

NCT05371054 2026-02-23

Study of VIP152, Venetoclax, and Prednisone (VVIP) in Relapsed/Refractory Lymphoid Malignancies

Phase 1/2 Completed

8 enrolled 20 charts

LymphoidOther hematologic neoplasm

Lymphoma, Lymphoma, Non-Hodgkin, Hematologic Neoplasms

NCT07416825 2026-02-18

Inter-Observer Delineation Differences in Esophageal Cancer GTV on MR, CT, and PET/CT Protokol šečerov Ermenc 28dec19

Phase NA Completed

23 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT04432597 2026-02-17

HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated Cancers

Phase 1/2 Active not recruiting

39 enrolled

GastrointestinalGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Oropharyngeal Neoplasms, Rectal Neoplasms

NCT04447027 2026-01-30

Romidepsin, CC-486 (5-azacitidine), Dexamethasone, and Lenalidomide (RAdR) for Relapsed/Refractory T-cell Malignancies

Phase 1 Completed

26 enrolled 24 charts

DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral

NCT07353229 2026-01-23

68Ga-Dotatate PET and MRI Guided Radiation Dose Escalation for High Risk Meningioma

Phase 1 Suspended

24 enrolled